Stock price and volume soar for Jazz Pharmaceuticals ahead of critical FDA advisory committee meeting (next week Friday, Aug 20). Price is up ~16% in 2 days and ~26% in 10 days. Once again, the pattern of stock direction follows that would be expected prior to an FDA-based catalyst event and the trading strategy works!!!
No comments:
Post a Comment